A biomedical engineer from the University of Technology Sydney and the CEO of NeoGenix Biosciences, Dr Steven Vasilescu, has invented an artificial intelligence tool that has the potential to revolutionise the treatment of infertility and address low sperm counts in men.
SpermSearch is a cutting-edge AI technology created to help identify viable sperm in semen samples, with a focus on men who have non-obstructive azoospermia, a condition in which they lack sperm to ejaculate.
Nevertheless, by processing photos of the samples that were instantly uploaded to the computer, SpermSearch was able to assess and identify healthy sperm in a matter of seconds.
“It can highlight a potentially viable sperm before a human can even process what they’re looking at,” he says.
Dr. Vasilescu and his team educated the AI by showing it millions of samples of sperm within intricate tissue in order to attain this amazing speed.
The UTS biomedical engineering team found SpermSearch to be 1,000 times faster than an expert embryologist in a scientific study they released.
10% of infertile men have this syndrome known as non-obstructive azoospermia, and SpermSearch, an AI tool, has been created to assist these guys.
According to Dr. Vasilescu, this process can take several employees six or seven hours, and there is a risk of exhaustion and accuracy.
Studies show a 50% reduction in sperm counts during the previous forty years, which has led to an increase in male infertility. This reduction is a result of a number of causes, such as pollution, smoking, bad diets, insufficient exercise, and high levels of stress.
SpermSearch has showed tremendous promise, but after a limited trial involving only seven individuals, it is currently at the proof-of-concept stage.